BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 29086571)

  • 1. Resolving the Ligand-Binding Specificity in c-MYC G-Quadruplex DNA: Absolute Binding Free Energy Calculations and SPR Experiment.
    Deng N; Wickstrom L; Cieplak P; Lin C; Yang D
    J Phys Chem B; 2017 Nov; 121(46):10484-10497. PubMed ID: 29086571
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Solution structure of a 2:1 quindoline-c-MYC G-quadruplex: insights into G-quadruplex-interactive small molecule drug design.
    Dai J; Carver M; Hurley LH; Yang D
    J Am Chem Soc; 2011 Nov; 133(44):17673-80. PubMed ID: 21967482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of a selective G-quadruplex DNA binder using a multistep virtual screening approach.
    Hou JQ; Chen SB; Zan LP; Ou TM; Tan JH; Luyt LG; Huang ZS
    Chem Commun (Camb); 2015 Jan; 51(1):198-201. PubMed ID: 25388435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disubstituted 1,8-dipyrazolcarbazole derivatives as a new type of c-myc G-quadruplex binding ligands.
    Chen WJ; Zhou CX; Yao PF; Wang XX; Tan JH; Li D; Ou TM; Gu LQ; Huang ZS
    Bioorg Med Chem; 2012 May; 20(9):2829-36. PubMed ID: 22484007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Using Molecular Dynamics Free Energy Simulation to Compute Binding Affinities of DNA G-Quadruplex Ligands.
    Deng N
    Methods Mol Biol; 2019; 2035():177-199. PubMed ID: 31444750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ligand-induced conformational preorganization of loops of c-MYC G-quadruplex DNA and its implications in structure-specific drug design.
    Harikrishna S; Kotaru S; Pradeepkumar PI
    Mol Biosyst; 2017 Jul; 13(8):1458-1468. PubMed ID: 28650023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-based design of platinum(II) complexes as c-myc oncogene down-regulators and luminescent probes for G-quadruplex DNA.
    Wang P; Leung CH; Ma DL; Yan SC; Che CM
    Chemistry; 2010 Jun; 16(23):6900-11. PubMed ID: 20437426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Benzothiazole hydrazones of furylbenzamides preferentially stabilize c-MYC and c-KIT1 promoter G-quadruplex DNAs.
    Pany SP; Bommisetti P; Diveshkumar KV; Pradeepkumar PI
    Org Biomol Chem; 2016 Jun; 14(24):5779-93. PubMed ID: 27021281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective Targeting of G-Quadruplex Structures by a Benzothiazole-Based Binding Motif.
    Buchholz I; Karg B; Dickerhoff J; Sievers-Engler A; Lämmerhofer M; Weisz K
    Chemistry; 2017 Apr; 23(24):5814-5823. PubMed ID: 28276093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comprehensive Thermodynamic Profiling for the Binding of a G-Quadruplex Selective Indoloquinoline.
    Funke A; Weisz K
    J Phys Chem B; 2017 Jun; 121(23):5735-5743. PubMed ID: 28531353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topology specific stabilization of promoter over telomeric G-quadruplex DNAs by bisbenzimidazole carboxamide derivatives.
    Dhamodharan V; Harikrishna S; Bhasikuttan AC; Pradeepkumar PI
    ACS Chem Biol; 2015 Mar; 10(3):821-33. PubMed ID: 25495750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Solution structure of the biologically relevant G-quadruplex element in the human c-MYC promoter. Implications for G-quadruplex stabilization.
    Ambrus A; Chen D; Dai J; Jones RA; Yang D
    Biochemistry; 2005 Feb; 44(6):2048-58. PubMed ID: 15697230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specific Stabilization of c-MYC and c-KIT G-Quadruplex DNA Structures by Indolylmethyleneindanone Scaffolds.
    Diveshkumar KV; Sakrikar S; Rosu F; Harikrishna S; Gabelica V; Pradeepkumar PI
    Biochemistry; 2016 Jun; 55(25):3571-85. PubMed ID: 27226253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of the equilibrium between G-quadruplex and duplex DNA in promoter of human c-myc oncogene by a pyrene derivative.
    Zhang Z; He X; Yuan G
    Int J Biol Macromol; 2011 Dec; 49(5):1173-6. PubMed ID: 21683090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel G-quadruplex stabilizing agents: in-silico approach and dynamics.
    Kar RK; Suryadevara P; Jana J; Bhunia A; Chatterjee S
    J Biomol Struct Dyn; 2013 Dec; 31(12):1497-518. PubMed ID: 23244447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ligand Selectivity in the Recognition of Protoberberine Alkaloids by Hybrid-2 Human Telomeric G-Quadruplex: Binding Free Energy Calculation, Fluorescence Binding, and NMR Experiments.
    Deng N; Xia J; Wickstrom L; Lin C; Wang K; He P; Yin Y; Yang D
    Molecules; 2019 Apr; 24(8):. PubMed ID: 31010072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The flanking sequence contributes to the immobilisation of spermine at the G-quadruplex in the NHE (nuclease hypersensitivity element) III1 of the c-Myc promoter.
    Keniry MA; Owen EA
    FEBS Lett; 2014 May; 588(10):1949-54. PubMed ID: 24735723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human MYC G-quadruplex: From discovery to a cancer therapeutic target.
    Wang W; Hu S; Gu Y; Yan Y; Stovall DB; Li D; Sui G
    Biochim Biophys Acta Rev Cancer; 2020 Dec; 1874(2):188410. PubMed ID: 32827579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bisaryldiketene derivatives: A new class of selective ligands for c-myc G-quadruplex DNA.
    Peng D; Tan JH; Chen SB; Ou TM; Gu LQ; Huang ZS
    Bioorg Med Chem; 2010 Dec; 18(23):8235-42. PubMed ID: 21036049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 12-N-Methylated 5,6-dihydrobenzo[c]acridine derivatives: a new class of highly selective ligands for c-myc G-quadruplex DNA.
    Liao SR; Zhou CX; Wu WB; Ou TM; Tan JH; Li D; Gu LQ; Huang ZS
    Eur J Med Chem; 2012 Jul; 53():52-63. PubMed ID: 22513122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.